Outpacebio logo
Outpacebio logo

Outpacebio

outpacebio.com
outpacebio.com • HQ: Seattle, United States • Venture - Series Unknown 2024 • 51-200 employees • Founded 2020 • Startup
HQ: Seattle, United States • Venture - Series Unknown 2024 • 51-200 employees • Founded 2020 • Startup
Actively hiring
Drug Discovery AI
Oncology Therapeutics
Cell & Gene Therapy
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$56M
1 round on record
Latest round
$56M
Venture round · Jul 2024 · 2 yr ago
Team
61
US Form 5500 (plan participants) · Dec 2025 · +5% in a year
Backers
4
RA Capital Management, Abstract
The money's age
Long since its last round
26 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 17, 2024 Raised a round Venture round $56M · SEC Form D 2020 Founded
Tractionpublic signals, read monthly
Web presence
top 5%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2024 $56M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Outpace Bio, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Aaron FosterExecutive OfficerSEC Form D
Charity ScriptureExecutive OfficerSEC Form D
Scott BoykenExecutive Officer, DirectorSEC Form D
Eric SollerExecutive OfficerSEC Form D
Marc LajoieExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
RA Capital Management fund Abstract fund Atinum Investment fund Playground fund
Investors in similar startupsfunds that back the companies most like this one
NEA
backs 858 Therapeutics
ARCH Venture Partners
backs Dispatch Bio
NFX
backs TwoStep
Hummingbird Ventures
backs Waypoint Bio
Illumina Ventures
backs Actym Therapeutics
M Ventures
backs TwoStep
Similar startupsby what they do, their industry and backers
TwoStep11-50 employees
TwoStep Therapeutics. Developing tumor-targeted therapies with broad applicability across solid tumors.
OncosenxVenture round $650k · 5 yr ago • Founded 2017 • 11-50 employees
The Next Generation in. OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid…
Actym TherapeuticsSeries A · this month • 51-200 employees
Actym Therapeutics is deploying its biologically brilliant bacteria drug delivery platform to treat cancer with powerful immunotherapies…
858 TherapeuticsVenture round $25.2M · 2 yr ago • 201-500 employees
ETX-19477 is a selective PARG inhibitor designed to address DNA damage response vulnerabilities and expand precision treatment options for…
Waypoint Bio11-50 employees
Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.
StratosvirVenture round · 7 mo ago • Founded 2020
Stratosvir. Revolutionizing cancer treatment through viral immunotherapy.

Visa sponsorship

  • United States · Filed H-1B visas in the last two years

Visa details by country

Overview

Revolutionizing solid tumor treatment through AI-powered protein engineering. OUTSMART™, OUTLAST™, and OUTSPACER™ technologies enhance CAR-T therapy safety and efficacy.

People

Aaron Foster
Executive Officer
SEC Form D
Charity Scripture
Executive Officer
SEC Form D
Scott Boyken
Executive Officer, Director
SEC Form D
Eric Soller
Executive Officer
SEC Form D
Marc Lajoie
Executive Officer, Director
SEC Form D
Jake Simson
Director
SEC Form D
Bahija Jallal
Director
SEC Form D
Vasudev Bailey
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Seattle United States
HQ
50-200 est. staff

Financials

Total raised
$56M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $56M Details